CLAUDIN 6 AS A NOVEL IMMUNOTHERAPEUTIC TARGET FOR CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS IN THE TREATMENT OF PEDIATRIC SOLID TUMORS

被引：0

作者：

Madsen, Peter ^{[1
,2
]}

Dickson, Conor ^{[1
]}

Harvey, Kyra ^{[3
]}

Wilson, Cullen ^{[1
]}

Patterson, Luke ^{[3
]}

Stern, Allison ^{[3
]}

Griffin, Crystal ^{[3
]}

Storm, Phillip ^{[1
,2
]}

Resnick, Adam ^{[1
]}

Gaida, Matthias ^{[4
,5
]}

Rengstl, Benjamin ^{[6
]}

Schlitter, Anna ^{[6
]}

Tureci, Ozlem ^{[5
,6
]}

Sahin, Ugur ^{[5
,6
]}

Flemmig, Carina ^{[6
]}

Foster, Jessica ^{[3
,7
]}

机构：

[1] Childrens Hosp Philadelphia, Neurosurg, Philadelphia, PA USA

[2] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA USA

[3] Childrens Hosp Philadelphia, Pediat Oncol, Philadelphia, PA USA

[4] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Mainz, Germany

[5] Univ Med Ctr, TRON, Translat Oncol, Mainz, Germany

[6] BioNTech SE, Oncol, Mainz, Germany

[7] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA USA

来源：

PEDIATRIC BLOOD & CANCER | 2023年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O258

引用

页码：S146 / S146

页数：1

共 50 条

[41] Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors
Morgan, Michael A.
Schambach, Axel
HUMAN GENE THERAPY, 2018, 29 (10) : 1083 - 1097
[42] In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors
Sun, Zhichen
Li, Rutian
Shen, Yun
Tan, Siyi
Ding, Naiqing
Xu, Ruihan
Wang, Xinyue
Wei, Jia
Liu, Baorui
Meng, Fanyan
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[43] Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL
Curran, Kevin J.
Riviere, Isabelle
Kobos, Rachel
Kernan, Nancy A.
Boulad, Farid
Prockop, Susan E.
Scaradavou, Andromachi
Renaud, Thomas M.
Shukla, Neerav
Steinherz, Peter G.
Park, Jae H.
Sauter, Craig S.
O'Reilly, Richard J.
Sadelain, Michel
Brentjens, Renier J.
BLOOD, 2014, 124 (21)
[44] In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors
Zhichen Sun
Rutian Li
Yun Shen
Siyi Tan
Naiqing Ding
Ruihan Xu
Xinyue Wang
Jia Wei
Baorui Liu
Fanyan Meng
Journal of Hematology & Oncology, 15
[45] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?
Salmikangas, Paula
Kinsella, Niamh
Chamberlain, Paul
PHARMACEUTICAL RESEARCH, 2018, 35 (08)
[46] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Paula Salmikangas
Niamh Kinsella
Paul Chamberlain
Pharmaceutical Research, 2018, 35
[47] Chimeric antigen receptor (CAR) NK cells for the treatment of allergy
Zabel, Maja
Kratzer, Bernhard
Trapin, Doris
Steinberger, Peter
Eitler, Jiri
Tonn, Torsten
Pickl, Winfried F.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 351 - 351
[48] Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
Di, Shengmeng
Li, Zonghai
SCIENCE CHINA-LIFE SCIENCES, 2016, 59 (04) : 360 - 369
[49] Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
Shengmeng Di
Zonghai Li
Science China(Life Sciences), 2016, 59 (04) : 360 - 369
[50] Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
Shengmeng Di
Zonghai Li
Science China(Life Sciences), 2016, (04) : 360 - 369

← 1 2 3 4 5 →